Ira Jacobs of Pfizer's 2015 Presentation

Pfizer shares their expertise on biosimilars on the horizon

Doctor Ira Jacobs is a fellowship trained surgical oncologist who is currently Pfizer’s oncology biosimilars global medical lead. Prior to Pfizer, Doctor Jacobs worked as a medical director in oncology global development at Amgen. He led clinical development programs in breast, lung, prostate, and bone cancers. Prior to transitioning into industry, Dr. Jacobs was a staff surgical oncologist.

We were excited to have Ira share his expertise on biosimilars on the horizon: opportunities and challenges in the United States at last year’s World Biosimilar Congress USA.

Download his presentation now >

Ira received his BA, MD, and MBA degrees from the George Washington University. He completed a general surgery residency and a surgical oncology fellowship. He is the author of more than 25 publications and has received numerous awards and honors.

You can now download his presentation to find out more about:

  • How biologics have made significant contributions to patient care
  • The expiration of many biologic patents in the coming years
  • The evolution of biologics and the advent of biosimilars from past to present
  • Definitions of biosimilars
  • Why education of the healthcare community is needed

Download his presentation now >

The World Biosimilar Congress USA is where biopharma developing biosimilars gather to discuss how to access the US market. This year’s event will take place May 19-20 at the Hilton San Diego Resort and Spa.

Click here to register now >